Invesco’s GSK GSK Stock Holding History

Invesco’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259K	Buy	+4,690	New	+$254K	﹤0.01%	3397
2025 Q1	–	Sell	-7,606	Closed	-$257K	–	3791
2024 Q4	$257K	Sell	7,606 -15,460	-67%	-$557K	﹤0.01%	3459
2024 Q3	$943K	Sell	23,066 -10,841	-32%	-$443K	﹤0.01%	2929
2024 Q2	$1.31M	Sell	33,907 -6,860	-17%	-$289K	﹤0.01%	2797
2024 Q1	$1.75M	Sell	40,767 -4,775	-10%	-$197K	﹤0.01%	2729
2023 Q4	$1.69M	Sell	45,542 -7,634	-14%	-$274K	﹤0.01%	2681
2023 Q3	$1.93M	Sell	53,176 -2,426	-4%	-$86.1K	﹤0.01%	2618
2023 Q2	$1.98M	Buy	55,602 +1,788	+3%	+$64.1K	﹤0.01%	2635
2023 Q1	$1.91M	Buy	53,814 +14,762	+38%	+$516K	﹤0.01%	2651
2022 Q4	$1.37M	Buy	39,052 +21,218	+119%	+$707K	﹤0.01%	2795
2022 Q3	$525K	Buy	17,834 +9,831	+123%	+$373K	﹤0.01%	3227
2022 Q2	$435K	Buy	8,003 +2,869	+56%	+$158K	﹤0.01%	3395
2022 Q1	$280K	Buy	5,134 +331	+7%	+$18K	﹤0.01%	3664
2021 Q4	$265K	Sell	4,803 -12,835	-73%	-$668K	﹤0.01%	3665
2021 Q3	$842K	Buy	17,638 +13,077	+287%	+$657K	﹤0.01%	3191
2021 Q2	$227K	Sell	4,561 -4,188	-48%	-$201K	﹤0.01%	3746
2021 Q1	$390K	Sell	8,749 -24,414	-74%	-$1.11M	﹤0.01%	3444
2020 Q4	$1.53M	Buy	33,163 +6,115	+23%	+$281K	﹤0.01%	2751
2020 Q3	$1.27M	Sell	27,048 -3,696	-12%	-$185K	﹤0.01%	2684
2020 Q2	$1.57M	Sell	30,744 -475,311	-94%	-$24.4M	﹤0.01%	2593
2020 Q1	$24M	Sell	506,055 -6,907	-1%	-$368K	0.01%	1121
2019 Q4	$30.1M	Sell	512,962 -4,337	-0.8%	-$241K	0.01%	1200
2019 Q3	$27.6M	Buy	517,299 +1,834	+0.4%	+$94.3K	0.01%	1227
2019 Q2	$25.8M	Buy	515,465 +429,896	+502%	+$21.6M	0.01%	1304
2019 Q1	$4.47M	Sell	85,569 -17,377	-17%	-$868K	﹤0.01%	2082
2018 Q4	$4.92M	Sell	102,946 -15,044	-13%	-$741K	﹤0.01%	1951
2018 Q3	$5.92M	Buy	117,990 +12,381	+12%	+$629K	﹤0.01%	2045
2018 Q2	$5.32M	Sell	105,609 -19,087	-15%	-$961K	﹤0.01%	2092
2018 Q1	$6.09M	Sell	124,696 -21,238	-15%	-$989K	﹤0.01%	1837
2017 Q4	$6.47M	Sell	145,934 -10,067	-6%	-$465K	﹤0.01%	1822
2017 Q3	$7.92M	Buy	156,001 +3,303	+2%	+$168K	﹤0.01%	1707
2017 Q2	$8.23M	Buy	152,698 +10,330	+7%	+$551K	﹤0.01%	1664
2017 Q1	$7.5M	Buy	142,368 +12,189	+9%	+$618K	﹤0.01%	1725
2016 Q4	$6.27M	Sell	130,179 -569,047	-81%	-$28.1M	﹤0.01%	1827
2016 Q3	$37.7M	Buy	699,226 +11,503	+2%	+$631K	0.01%	901
2016 Q2	$37.3M	Sell	687,723 -11,545	-2%	-$608K	0.01%	893
2016 Q1	$35.4M	Sell	699,268 -1,918,194	-73%	-$95.5M	0.01%	887
2015 Q4	$132M	Sell	2,617,462 -139,144	-5%	-$7.09M	0.05%	403
2015 Q3	$132M	Sell	2,756,606 -1,368,116	-33%	-$71.2M	0.06%	388
2015 Q2	$215M	Sell	4,124,722 -1,867,084	-31%	-$105M	0.08%	285
2015 Q1	$346M	Sell	5,991,806 -383,669	-6%	-$22M	0.13%	182
2014 Q4	$341M	Buy	6,375,475 +195,108	+3%	+$10.9M	0.13%	180
2014 Q3	$355M	Buy	6,180,367 +2,775,861	+82%	+$170M	0.14%	167
2014 Q2	$228M	Sell	3,404,506 -1,064,988	-24%	-$72.1M	0.09%	275
2014 Q1	$299M	Sell	4,469,494 -252,112	-5%	-$17M	0.12%	196
2013 Q4	$315M	Buy	4,721,606 +1,823	+0%	+$118K	0.13%	174
2013 Q3	$296M	Sell	4,719,783 -455,104	-9%	-$29.3M	0.13%	175
2013 Q2	$323M	Buy	+5,174,887	New	+$328M	0.15%	147

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Invesco's GSK Position: Q1 2026 in Review

Invesco opened a new position in GSK (GSK) in Q1 2026: 4,690 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #3397 among its holdings. This is a return to the name: Invesco previously reported a position in GSK as recently as Q4 2024.

Invesco first reported a position in GSK in Q2 2013 and has held it in 48 quarters since. The position peaked at $355M in Q3 2014. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Invesco held 4,690 shares of GSK worth $259K as of Q1 2026.
GSK was a new Invesco position in Q1 2026.
GSK made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3397 holding.
Invesco first reported a position in GSK in Q2 2013 and has held it in 48 quarters since.
Invesco's GSK position peaked at $355M in Q3 2014.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.